Skip to content

Living well with multiple morbidity

Living well with multiple morbidity: the development and evaluation of a primary care-based complex intervention to support patients with multiple morbidities

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN34092919
Enrollment
160
Registered
2013-01-14
Start date
2012-07-23
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generic Health Relevance Not Applicable

Interventions

CARE Plus, Exploratory cluster RCT to test feasibility of carrying out complex intervention in high deprivation setting
Follow Up Length: 12 months Randomisation at practice level will then take place after baseline measurements are completed, with four practices randomised to control group and four to intervention.
1. Connecting with the person (not just the patient or the diseases) 2. Assessing issues holistically (using a bio-psycho-social framework) 3. Responding empathically and positively (validating suffer

Sponsors

NHS Greater Glasgow & Clyde (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For participating practices, the inclusion criteria are: NHS Greater Glasgow and Clyde general medical practices serving socio-economically deprived populations that have previously registered interest in the study. For participating patients, the inclusion criteria are: 1. Males and females who are aged between 30 and 65 years 2. Who have two or more long term conditions 3. Whose healthcare provider believes are likely to benefit from and participate in the intervention for the duration of the study

Exclusion criteria

Exclusion criteria: Practices will be excluded in the majority of the GP principals: 1. Do not agree to deliver the intervention 2. Cannot attend the first Care PLUS training session Patients will be excluded if they are: 1. Unable to give informed consent to participate, including those with severe learning disability, severe active mental health problems (active psychosis, schizophrenia, bi-polar illness, psychotic depression, severe depression including active suicideality), severe dementia or other cognitive impairments. 2. Terminally ill or considered by GP as likely to die within next 12 months. 3. Unable to understand spoken and written Eglish, as we do not have the finances available to pay for translators.

Design outcomes

Primary

MeasureTime frame
1. Health-related quality of life (Euro-Qol 5D-5L) 2. Well-Being (W-BQ12) Measured at baseline, 6 months, 12 months

Secondary

MeasureTime frame
1. Hospital Anxiety and Depression Scale (HADS) 2. Self-efficacy 3. Self-esteem: The questionnaire will also include demographic and socio-economic status items, self-rated multimorbidity burden 4. Self-rated general health 5. Compliance with medication 6. CARE measure and Patient Enablement Instrument (PEI) will be used at the first consultation in both groups, and then retrospectively at 6 and 12 months on the participating patients (n=200). Practices will also collect 100 such measures on consecutive adult patients not in the study at baseline, 6 months and 12 months to ascertain any effects of the intervention on consultation quality in general. An economic analysis will also be carried out, based on the EQOL utility scores, and health service utilisation in control and intervention groups.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026